Eirik Klami Kristianslund

Postdoc
https://orcid.org/0000-0002-4963-3285

View Google Scholar profile

See publications in PubMed

Education

Doctor of Medicine (MD) at the Faculty of Medicine, University of Oslo (2013)
Doctorate (PhD) at the Faculty of Medicine, University of Oslo (2013)

Position

Postdoc., Clinic for Rheumatology, Outpatient Clinic and Research, Diakonhjemmet Hospital
Senior Consultant in Rheumatology, Clinic for Rheumatology, Outpatient Clinic and Research, Diakonhjemmet Hospital

Field of interest

Inflammatory joint diseases
Arthritis (rheumatoid arthritis, RA)
Inflammatory back disorders (axial spondyloarthritis, SpA)
Psoriatic arthritis (PsA)
Physical activity
Therapeutic drug monitoring
Digital home monitoring
Randomized controlled trials
Observational studies

Other

Head of the Norwegian Interdisciplinary Organization in Rheumatology (NIOR)

Email

This email address is protected from spambots. You need JavaScript enabled to view it.

Telephone

+47 40042792

Visiting address

Diakonhjemmet Hospital
Superintendent's residence
Reidar Kobros vei 8
0370 Oslo

Postal address

Diakohjemmet Hospital
PO Box 23 Vinderen
0319 Oslo

Projects

WP1 - Optimized medical interventions

ARCTIC FORWARD

10-year follow-up of patients with rheumatoid arthritis who received structured treatment-to-target therapy in the early phase of the disease.

WP1 - Optimized medical interventions

MethMax

Maximizing treatment effect

WP6 - Dechiphering long-term outcomes

NOR-DMARD

The Norwegian register for antirheumatic drugs.

WP5 - Innovative approaches to remote care

NOR-Flare

Remote follow-up of patients with rheumatoid arthritis

WP1 - Optimized medical interventions

RA-DRUM

Therapeutic drug monitoring in patients with rheumatoid arthritis (RA-DRUM)

WP5 - Innovative approaches to remote care

ReMonit

Digital home monitoring of patients with spondyloarthritis

WP5 - Innovative approaches to remote care

ReMonit Gout

Gout management app

WP7 - Empowering the individual

KICK

SPONDYLARITE Fitness

WP1 - Optimized medical interventions

SQUEEZE

Maximizing the effectiveness of prescription drugs for rheumatoid arthritis

Publications

Publications retrieved from the National Science Archives (NVA):

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomized controlled trial

2026

Remote personalized exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomized controlled trial

2026

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial

2026

A head-to-head comparison of TNF-α inhibitors as the first biological treatment of rheumatoid arthritis

2026

Disparities in the organization of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

2025

Feasibility of Long-Term Physical Activity Measurement With a Wearable Activity Tracker in Patients With Axial Spondyloarthritis: 1-Year Longitudinal Observational Study

2025

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomized controlled noninferiority trial

2025

Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population

2025

Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study

2025

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis – results from 14 European countries

2025

Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration

2024

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

2024

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

2024

A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study

2024

Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

2024

Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study

2024

Interstitial lung disease in rheumatoid or psoriatic arthritis patients initiating biologics, and controls - data from five Nordic registries

2024

Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline

2024

Therapeutic serum level for adalimumab in rheumatoid arthritis: exploratory analyzes of data from a randomized phase III trial

2024

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

2024

Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

2023

Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

2023

Definition of rheumatoid arthritis flare based on SDAI and CDAI

2023

Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases

2023

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

2023

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

2023

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

2023

Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

2023

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

2023

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

2023

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway

2023

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

2023

Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

2023

Rheumatology congresses post COVID-19: we cannot regress

2023

After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries

2022

Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD

2022

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

2022

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

2022

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31,846 patients with rheumatoid arthritis in 19 registers from the JAK-pot' collaboration

2022

Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

2022

Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

2021

Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: A Nordic population-based cohort study

2021

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14,868 patients with spondyloarthritis

2020

Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register

2020

The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status

2020

Treatment response and drug retention rates in 24,195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

2019

Drug Retention of Biological DMARDs in Rheumatoid Arthritis Patients: The Role of Baseline Characteristics and Disease Evolution

2019

Comparative Effectiveness of TNF Inhibitors and Tocilizumab With and Without Conventional Synthetic Disease-Modifying Antirheumatic Drugs in a pan-European Observational Cohort of Bio-Naïve Patients With Rheumatoid Arthritis

2019

Retention and Response Rates in 14,261 PsA Patients Starting TNF Inhibitor Treatment-Results From 12 Countries in EuroSpA

2019

Imputing Missing Data of Function and Disease Activity in Rheumatoid Arthritis Registers: What Is the Best Technique?

2019

No Association Between Risk of Anterior Cruciate Ligament Rupture and Selected Candidate Collagen Gene Variants in Female Elite Athletes From High-Risk Team Sports

2019

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

2018

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study

2018

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

2018

Normative Quadriceps and Hamstring Muscle Strength Values for Female, Healthy, Elite Handball and Football Players

2018

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyzes from the pan-European TOCERRA register collaboration

2018

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

2018

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls

2018

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study

2017

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study

2017

Association between Lower Extremity Muscle Strength and Noncontact ACL Injuries

2016

The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries in Female Elite Soccer and Handball Players : A Prospective Cohort Study of 710 Athletes

2016

The effect of thigh marker placement on knee valgus angles in vertical drop jumps and sidestep cutting

2015

Physiotherapists Can Identify Female Football Players With High Knee Valgus Angles During Vertical Drop Jumps Using Real-Time Observational Screening

2014

Expressing the joint moments of drop jumps and sidestep cutting in different reference frames – does it matter?

2014

Sidestep cutting technique and knee abduction loading: implications for ACL prevention exercises

2014

Comparison of Drop Jumps and Sport-Specific Sidestep Cutting Implications for Anterior Cruciate Ligament Injury Risk Screening

2013

Effect of low pass filtering on joint moments from inverse dynamics: Implications for injury prevention

2012

Eirik Klami Kristianslund

Education

Position

Field of interest

Other

Email

Telephone

Visiting address

Postal address

Projects

Publications

Publications retrieved from the National Science Archives (NVA):

An international, multicentre, interventional, randomised, assessor-blinded trial to MAXimise the METHotrexate therapy potential in patients with active rheumatoid arthritis (MethMax trial): study protocol for a randomized controlled trial

Remote personalized exercise in axial spondyloarthritis: the SPARK trial – protocol for a 6-month randomized controlled trial

The Effect of Certolizumab Pegol Dose and Dose Changes on Plasma Trough Levels: Data From a Randomized Phase III Trial

A head-to-head comparison of TNF-α inhibitors as the first biological treatment of rheumatoid arthritis

Disparities in the organization of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Feasibility of Long-Term Physical Activity Measurement With a Wearable Activity Tracker in Patients With Axial Spondyloarthritis: 1-Year Longitudinal Observational Study

Remote monitoring or patient-initiated care in axial spondyloarthritis: a 3-armed randomized controlled noninferiority trial

Health-related Quality of Life in DMARD-treated adults with Juvenile Idiopathic Arthritis Compared to Rheumatoid Arthritis and the General Population

Interchangeability of patient pain, fatigue and global scores in patients with spondyloarthritis - a registry-based simulation study

The relationship between lifestyle factors and outcome of treatment with TNFα inhibitors in axial spondyloarthritis – results from 14 European countries

Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration

Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

A validation of register-derived diagnoses of interstitial lung disease in patients with inflammatory arthritis: data from the NOR-DMARD study

Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

Patients with axial spondyloarthritis reported willingness to use remote care and showed high adherence to electronic patient-reported outcome measures: an 18-month observational study

Interstitial lung disease in rheumatoid or psoriatic arthritis patients initiating biologics, and controls - data from five Nordic registries

Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline

Therapeutic serum level for adalimumab in rheumatoid arthritis: exploratory analyzes of data from a randomized phase III trial

Proactive therapeutic drug monitoring of biologic drugs in patients with inflammatory bowel disease, inflammatory arthritis, and psoriasis: systematic review and meta-analysis

Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial

Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

Definition of rheumatoid arthritis flare based on SDAI and CDAI

Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases

Second and third TNF inhibitors in European patients with axial spondyloarthritis: effectiveness and impact of the reason for switching

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

Willingness, perceived facilitators and barriers to use remote care among healthcare professionals – a cross-sectional study

Commonalities and differences in set-up and data collection across European spondyloarthritis registries — results from the EuroSpA collaboration

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD)

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Exposure to specific tumor necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Rheumatology congresses post COVID-19: we cannot regress

After JAK inhibitor failure: to cycle or to switch, that is the question - data from the JAK-pot collaboration of registries

Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD

European bio-naïve spondyloarthritis patients initiating TNF inhibitor: time trends in baseline characteristics, treatment retention and response

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31,846 patients with rheumatoid arthritis in 19 registers from the JAK-pot' collaboration

Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries

Effectiveness of a Second Biologic After Failure of a Non–tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis

Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: A Nordic population-based cohort study

Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14,868 patients with spondyloarthritis

Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register

The Patient Experienced Symptom State (PESS): a patient-reported global outcome measure that may better reflect disease remission status

Treatment response and drug retention rates in 24,195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration

Drug Retention of Biological DMARDs in Rheumatoid Arthritis Patients: The Role of Baseline Characteristics and Disease Evolution

Comparative Effectiveness of TNF Inhibitors and Tocilizumab With and Without Conventional Synthetic Disease-Modifying Antirheumatic Drugs in a pan-European Observational Cohort of Bio-Naïve Patients With Rheumatoid Arthritis

Retention and Response Rates in 14,261 PsA Patients Starting TNF Inhibitor Treatment-Results From 12 Countries in EuroSpA

Imputing Missing Data of Function and Disease Activity in Rheumatoid Arthritis Registers: What Is the Best Technique?

No Association Between Risk of Anterior Cruciate Ligament Rupture and Selected Candidate Collagen Gene Variants in Female Elite Athletes From High-Risk Team Sports

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study

Comparative effectiveness of subcutaneous tocilizumab versus intravenous tocilizumab in a pan-European collaboration of registries

Normative Quadriceps and Hamstring Muscle Strength Values ​​for Female, Healthy, Elite Handball and Football Players

Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: Data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study

Association between Lower Extremity Muscle Strength and Noncontact ACL Injuries

The Vertical Drop Jump Is a Poor Screening Test for ACL Injuries in Female Elite Soccer and Handball Players : A Prospective Cohort Study of 710 Athletes

The effect of thigh marker placement on knee valgus angles in vertical drop jumps and sidestep cutting

Physiotherapists Can Identify Female Football Players With High Knee Valgus Angles During Vertical Drop Jumps Using Real-Time Observational Screening

Expressing the joint moments of drop jumps and sidestep cutting in different reference frames – does it matter?

Sidestep cutting technique and knee abduction loading: implications for ACL prevention exercises

Comparison of Drop Jumps and Sport-Specific Sidestep Cutting Implications for Anterior Cruciate Ligament Injury Risk Screening

Effect of low pass filtering on joint moments from inverse dynamics: Implications for injury prevention

Privacy Settings

Normative Quadriceps and Hamstring Muscle Strength Values for Female, Healthy, Elite Handball and Football Players